Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis



Status:Recruiting
Conditions:Arthritis, Lupus, Rheumatoid Arthritis
Therapuetic Areas:Immunology / Infectious Diseases, Rheumatology
Healthy:No
Age Range:18 - 70
Updated:3/27/2019
Start Date:November 17, 2017
End Date:September 8, 2022
Contact:Pfizer CT.gov Call Center
Email:ClinicalTrials.gov_Inquiries@pfizer.com
Phone:1-800-718-1021

Use our guide to learn which trials are right for you!

A PHASE 1, RANDOMIZED, MULTI-CENTER, DOUBLE-BLIND, SPONSOR OPEN, PLACEBO-CONTROLLED, SINGLE AND MULTIPLE DOSE-ESCALATION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF PF-06835375 IN SUBJECTS WITH SEROPOSITIVE SYSTEMIC LUPUS ERYTHEMATOSUS OR RHEUMATOID ARTHRITIS

This is a Phase 1 single and multiple dose escalation study to evaluate the safety,
tolerability, pharmacokinetics, and pharmacodynamics of PF-06835375 in subjects with
seropositive SLE or RA. The design is double-blind, sponsor open and placebo controlled. This
study will include two parts: Part A and Part B. Part A will consist of single ascending dose
cohorts, Part B of multiple ascending dose cohorts. This study will enroll up to a total of
approximately 112 subjects at approximately 10 sites.


Inclusion Criteria:

- Patients with Rheumatoid Arthritis: confirmed diagnosis according to 2010 ACR/EULAR
criteria with symptom duration at least 6 months and positive with Rheumatoid Factor
and/or anti citrullinated peptide antibody

- Patients with Systemic Lupus Erythematosus: Confirmed diagnosis according to the SLICC
Classification Criteria with symptom duration at least 6 months and at least one of
the following: positive antinuclear antibody titer, positive anti-dsDNA, anti-Smith
antibodies

Exclusion Criteria:

- Active central nervous system manifestations, systemic vasculitis or
pleuro/pericarditis

- Active lupus nephritis

- Treatment with B cell depleting agents within 52 weeks prior to screening
We found this trial at
15
sites
8750 Wilshire Boulevard
Beverly Hills, California 90211
21
mi
from 91732
Beverly Hills, CA
Click here to add this to my saved trials
860 Peachwood Drive
DeLand, Florida 32720
(386) 740-0770
Site Overview Avail Clinical Research is a renowned and experienced clinical research site conducting Phase...
2176
mi
from 91732
DeLand, FL
Click here to add this to my saved trials
2147 Northeast Coachman Road
Clearwater, Florida 33765
2119
mi
from 91732
Clearwater, FL
Click here to add this to my saved trials
Anniston, Alabama 36207
1842
mi
from 91732
Anniston, AL
Click here to add this to my saved trials
Baltimore, Maryland 21225
?
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Catonsville, Maryland 21228
?
mi
from 91732
Catonsville, MD
Click here to add this to my saved trials
Clearwater, Florida 33765
?
mi
from 91732
Clearwater, FL
Click here to add this to my saved trials
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Duncansville, Pennsylvania 16635
2201
mi
from 91732
Duncansville, PA
Click here to add this to my saved trials
?
mi
from 91732
Glendale, CA
Click here to add this to my saved trials
Glendale, California 91206
?
mi
from 91732
Glendale, CA
Click here to add this to my saved trials
Los Angeles, California 90048
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
7912 Forest City Road
Orlando, Florida 32810
2180
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
3100 Duraleigh Road
Raleigh, North Carolina 27612
2214
mi
from 91732
Raleigh, NC
Click here to add this to my saved trials
South Miami, Florida 33143
2318
mi
from 91732
South Miami, FL
Click here to add this to my saved trials